In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves

EuroIntervention 2016;12:909-917. DOI: 10.4244/EIJV12I7A149

Matheus Simonato
Matheus Simonato1,2; Ali N. Azadani3, PhD; John Webb1, MD; Jonathon Leipsic1, MD; Ran Kornowski4, MD; Alec Vahanian5, MD; David Wood6, MD; Nicolo Piazza7, MD; Susheel Kodali8, MD; Jian Ye1, MD; Brian Whisenant9, MD; Diego Gaia2, MD; Mina Aziz1, MD; Tilak Pasala9, MD; Julinda Mehilli10, MD; Harindra C. Wijeysundera11, MD; Didier Tchetche12, MD; Neil Moat13, MD; Rui Teles14, MD; Anna Sonia Petronio15
1. St. Paul’s Hospital, Vancouver, BC, Canada; 2. Escola Paulista de Medicina – UNIFESP, São Paulo, Brazil; 3. University of Denver, Denver, CO, USA; 4. Rabin Medical Center, Petah Tikva, Israel; 5. Hôpital Bichat-Claude Bernard, Paris, France; 6. Vancouv

Aims: Transcatheter heart valve (THV) implantation in failed bioprosthetic valves (valve-in-valve [ViV]) offers an alternative therapy for high-risk patients. Elevated post-procedural gra

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

aortic valve replacementcirculatory in vitro studieshaemodynamicsheart valve prosthesisvalve-in-valve
Interventions for valvular diseaseTAVITools, devices and techniques
Read next article
Percutaneous repair of the tricuspid valve using a novel cinching device: acute and chronic experience in a preclinical large animal model

Latest news